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INTRODUCTION 
The diagnostic process for cancer is 
complex and multifaceted,1 with ongoing 
public pressure to expedite and improve it. 
The NHS Five Year Forward View included a 
recommendation to develop and implement 
the Faster Diagnosis Standard (FDS), in 
which patients will receive a diagnosis or all-
clear for cancer within 28 days of referral for 
diagnostic testing.2 This new standard aims to 
facilitate a patient-centred, flexible, and rapid 
approach to cancer diagnosis/non-diagnosis. 
It is different from existing standards such 
as urgent referrals, that is, where patients 
are seen by a specialist within 2 weeks,3 
because it extends further along the cancer 
care pathway to include the time it takes to 
confirm or rule out a diagnosis, rather than 
simply time to the first specialist appointment. 
It is hoped that implementing the standard 
will expedite cancer diagnosis, and provide 
faster reassurance for the majority of people 
who will not have a cancer diagnosis. 
Evidence surrounding missed 
opportunities in cancer diagnosis 
emphasises the importance of patient 
empowerment to minimise risk of 
prolonged diagnostic intervals. Patients 
need to be engaged, or invested, to follow 
up on test results, re-consult their GP if 
symptoms persist or worsen, and attend 
follow-up appointments.1 Although patient 
preferences have been explored regarding 
communication of a confirmed cancer 
diagnosis,4–6 and whether or not to initiate 
referral,7,8 there has been limited study of 
patient communication preferences during 
referral for diagnostic testing to confirm 
or rule out cancer.9 Existing studies have 
used vignette methodology to quantitatively 
explore patient preferences for referral, for 
example, demonstrating preferences for 
investigation at 1% cancer risk,7,8 whereas 
previous qualitative research with people 
referred on an urgent referral pathway 
focused on symptom appraisal and help 
seeking, rather than exploring referral 
experiences.10 
To date, patient views at the point of referral 
for diagnostic tests to possibly confirm, or 
rule out, cancer have not been explored and 
there has been no research to explore public 
attitudes towards the new FDS. As such, 
little guidance exists for primary care staff 
regarding navigation of these conversations 
at point of referral. There may also be 
reticence in raising the possibility of cancer 
at this stage of the diagnostic process, when 
the majority (90%) of people referred on 
cancer pathways have cancer ruled out.3 
This study explored public attitudes towards 
the FDS, within the context of people’s recent 
referral experiences. 
METHOD
Participant selection
The authors conducted focus groups in 
two different geographical areas (Guildford, 
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Southeast England; Bradford, Yorkshire 
and Humber) to access a wide range of 
opinions and referral experiences, and 
enable participant reflection and discussion 
regarding the FDS. Guildford was chosen 
as the study’s southern site for practical 
reasons as it is where the study team is 
based. The authors chose Bradford to 
include an area with a different demographic 
profile. Bradford has a larger population 
(approximately 500 000 versus 140 000) 
and is more ethnically diverse (64% versus 
84% of people identify as white British 
respectively).11,12 Neither site was involved in 
the pilot programme for the FDS.
Focus groups allow examination of 
people’s health service experiences, enabling 
group discussions to explore attitudes in 
a way that may be less accessible with 
individual interviews.13 Eligible participants 
were approached by market research agency 
Saros Research Ltd through their established 
volunteer databases over a 4-week period. 
Purposive sampling ensured that location 
(rural or urban), sex, and education level 
were evenly distributed among the sample. 
The authors chose to run four focus groups 
following a recent review suggesting that 
90% of themes are discoverable within three 
to six focus groups.14 Sample size (n = 6–8 
per focus group) was determined based on 
recommended numbers for focus groups.15 
To be eligible, participants had to:
• be aged ≥50 years; and
• have been referred from primary care for 
one or more of the following diagnostic 
investigations within the last 6 months: 
ultrasound scan, computed tomography/
magnetic resonance imaging (CT/
MRI) scan, mammogram, chest X-ray, 
colonoscopy/sigmoidoscopy, endoscopy 
(other), biopsy. These investigations 
were taken from the authors’ previous 
research exploring the impact of an all-
clear diagnosis on subsequent help-
seeking for potential cancer symptoms.16 
The majority of referrals under the 
FDS are likely to have cancer ruled out,3 
thus excluding people with a previous or 
current diagnosis of cancer ensured a 
homogeneous group to focus on referral 
experiences and attitudes towards the FDS.
Two focus groups were conducted in each 
location (Guildford: University of Surrey; 
Bradford: Community Empowerment 
Network (CNet) community centre, 
Manningham). Participants provided informed 
consent and completed a demographic 
questionnaire before taking part. Focus 
groups lasted approximately 90 minutes. 
Focus groups
The topic guide was developed with input 
from cancer survivors, members of the 
public, and academics external to the 
research team (the topic guide is available 
from the authors). Participants were invited 
to share the most important or meaningful 
thing to them when being referred by their 
GP for a clinical test. These topics were then 
explored more fully, with participants asked 
to reflect on how their referral experience 
could have been improved. Following these 
initial reflections, a definition of the FDS 
was presented to the group:
‘The Faster Diagnosis Standard is a new 
care standard, so people referred by their 
doctor for certain clinical tests will find out 
whether or not they have cancer within 
28 days of the referral.’1
Participants were asked for their 
thoughts on the standard, and in what ways 
their experience of being referred, tested, 
and receiving the results might have been 
influenced, had they been referred under 
the standard. Participants were also asked 
whether they thought they had a role to play 
in meeting the standard, and to explain their 
reasoning. 
Analysis
Focus group discussions were digitally 
audio-recorded and transcribed verbatim. 
Transcripts were deductively analysed 
using thematic analysis.17,18 For each focus 
group a single researcher familiarised 
themselves with the transcript, abstracting 
the conversation for analysis meetings 
with three others from the research 
team. The initial setting of themes within 
a framework was reviewed for fit, and 
further refined by the research team. 
Refinement was inductive and derived from 
concepts grounded in the data using mind 
maps. This allowed concept integration 
into meaningful themes, and associations 
How this fits in
The Faster Diagnosis Standard (FDS) 
aims to ensure patients will have cancer 
ruled out or diagnosed within 28 days of 
referral for diagnostic testing. There is 
currently no evidence demonstrating how 
the public may view this standard. This 
study highlights the pivotal role of the GP 
within the FDS, as perceived by the public. 
Recommendations are made to facilitate 
GP–patient conversations at the point of 
referral under the FDS.
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between themes to be explored. Key 
recommendations were generated and 
conveyed at an event at Cancer Research 
UK attended by academics external to the 
project, Cancer Research UK staff, and 
patient representatives. Event feedback 
was used to finalise the analysis and 
recommendations.
RESULTS
Participants
The focus groups had a total of 29 participants 
and a balanced sex distribution (males 
n = 14, females n = 15) and settlement area 
(urban n = 13, rural n = 16), and included 
a range of education levels (Table 1). Many 
experienced more than one clinical test 
(n = 16). The most commonly reported 
clinical tests were ultrasound (59%, n = 17) 
and CT scan (38%, n = 11). Less common 
tests included mammogram (7%, n = 2) and 
biopsy (3%, n = 1). Participants reported a 
range of comorbidities (Table 2). 
 
Cynicism about how the FDS will improve 
existing referral speeds 
The FDS aims to standardise referral speed 
and diagnostic pathways, yet participants 
described a referral system already felt to 
be speedy in terms of reaching the point of 
diagnostic testing:
‘I am partly worried about the failing NHS 
and I thought I’m just going to get fobbed 
off here and told to go take a pill, and so I 
was quite impressed that I got access to all 
these specialist services, and as quickly as 
I did.’ (Bradford [B]1, male [M])
In this context, the FDS was not 
considered fast enough. Some expressed 
concerns that FDS roll-out may ultimately 
extend waiting times, running counter to its 
intended effect: 
‘If that’s the new standard, 28 days, then 
we’ve got to be frightened of what we’ve got 
now, you know, that’s the frightening thing.’ 
(B2, M)
‘So what happens is that as soon as 
28 days appears anywhere that becomes 
the standard, rather than the last resort, 
so when suddenly you go, well we’ve got 
28 days, we’ll give them a … we’ll get in 
touch with them in 3 weeks’ time […].’ 
(G [Guildford] 2, M)
This reticence was also apparent when 
groups discussed existing speed-based 
‘targets’. Awareness about what these 
Table 1. Demographic characteristics, N = 29 
Characteristic n
Age  
 Mean (SD), years  58.76 (6.39)
Sex ratio  
 Male: female 14:15
Ethnicity  
 White/white British/white other 25 
 Asian/Asian British 3 
 Black/African/Caribbean/black British 1
Location  
 Southeast (Guildford) 15 
 Yorkshire/Humber (Bradford) 14
Environment  
 Urban 13 
 Rural 16
Education level  
 Degree or higher degree 15 
 Higher education qualification below degree level  3 
 A-levels (AS levels/Advanced diploma/equivalent) 3 
 O Level/GCSE 8
Marital status  
 Single/never married 2 
 Married/living with partner 23 
 Divorced/separated 3 
 Widowed 1
Car ownership  
 No 2 
 Yes, one 12 
 Yes, two or more 15
Living arrangements  
 Home owned outright 10 
 Home owned with mortgage 16 
 Renting from local authority or housing association 2 
 Renting privately 1
Employment status  
 Employed full-time 3 
 Employed part-time 10 
 Unemployed 1 
 Self-employed 5 
 Full-time homemaker 2 
 Retired 7 
 Disabled or too ill to work 1
Smoking status 
 No, has never smoked 17 
 Not now, but used to smoke 9 
 Yes, is current smoker 2  
 Missing 1
Test received  
 Ultrasound 17 
 CT scan 11 
 Endoscopy (other) 4 
 Mammogram 2 
 Chest X-ray 6 
 Colonoscopy/sigmoidoscopy 6 
 Biopsy 1 
 PSA 3
Presence of disease in close family/extended family/friend  
 Heart disease 18 
 Cancer 24 
 Asthma 11
CT = computed tomography. PSA = prostate-specific antigen.
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targets were or how the new standard 
might fit was limited:
‘There’s something about this already, so 
certain types of cancers they could, within 
6 weeks if you go to a, I think breast cancer 
is one of them, the doctors, so that’s only a 
couple of days, at the moment it’s 6 weeks 
they tell you that when you go to the doctors 
for certain types of cancers, right, you will be 
on the path, so if you’re looking at 28 days, 
so now we’re talking working days, that’s 
only 2 days shorter and that’s available at 
the moment, so … ’ (G1, M)
Reassurance or support valued as highly 
as speed
Other aspects of GP interactions arose 
that were felt to be as important as speed. 
For example, the GP was perceived to 
have a pivotal role in providing information 
and reassurance regarding the referral, 
based on their knowledge of the patient’s 
information needs, which were considered 
highly individual:
‘It depends on what the problem is and of 
course the individual, so the GP actually 
knows the individual, they can actually judge 
whether they need a lot more reassurance 
and information, as far as I was concerned 
I wanted information and, you know, being 
given options, and it’s pretty straightforward, 
but I know that some people would actually 
want a lot more reassurance, so I think 
it is key to it … GP actually knowing the 
patients …’ (B2, M)
‘There are some of us that want to know 
everything by the time we leave the GPs 
and others would prefer to be in, you know, 
ignorance, so it must be very difficult for 
them to know what to do.’ (G2, M)
People also emphasised the importance 
of feeling listened to and validated by the 
GP’s response and decision to refer: 
‘Being listened to I think, so it’s being heard, 
and my GP was fine, has really really been 
… it was really quick, it couldn’t have been 
quicker, but it was feeling … I suppose it’s 
being listened to and then almost like being 
believed.’ (G1, female [F])
Knowing what to expect through more 
transparent referral processes 
Participants described a lack of transparency 
in the referral process, and concern about 
getting lost in the system. This feeling was 
exacerbated by not knowing what to expect, 
and/or being unable to draw upon past 
experiences due to inconsistency between 
one referral and the next:
‘… and then right OK, there’s an appointment 
I come, I don’t actually know which hospital 
it is, I presume it’s the local one so until 
I get the letter I actually haven’t got that 
confirmation, but I’d just like them to get 
on with it and, but obviously I have to know 
exactly where I’m going, that would my only 
thing, I would like to know exactly where 
I’m going on the day and I know I’m going 
to be seen and not passed from pillar to 
post.’ (G1, F)
‘Yeah, I think that’s probably it, yeah, the 
disparity between everyone’s experiences, 
and also within your own experiences, of 
similar situations occurring, and suddenly 
things happen, and it is that lack of 
consistency that I think frustrates people so 
much.’ (G2, M)
Participants described themselves as 
passive actors in a system that was ‘done to 
them’ or in which ‘suddenly things happen’, 
suggesting that individuals experience a 
loss of agency when entering the referral 
system, and feel pulled along by various 
processes. Increasing consistency and 
transparency of these processes was 
perceived as a means to regain this sense 
of agency:
‘Sometimes it’s also about feeling like you 
have some control of what’s going on, 
rather than it’s being done to, so maybe 
trying to get more of a … improve the 
standard of that communication and be 
more consistent, so wherever you are and 
wherever, you know, whatever part you’re 
in, it’s a standard way of doing things.’ 
(B2, F)
Opaque and inconsistent processes were 
exemplified within participant experiences 
of obtaining test results, having to chase 
for them or receiving them by letter without 
support:
‘You’re working, and you’ve sort of trying 
to find time in-between your work to make 
phone calls and then you can’t get through 
or they say they haven’t got the results and 
then my surgery did tell me to ring the 
hospital, where I thought really they should 
have got the results rather than me having 
to ring up, and then I had quite a negative 
experience with the medical secretary and 
I sort of said to her, “Well what if you’d 
got cancer then, what if it’s something 
serious?” and she just brushed it off and 
Table 2. Comorbidities 
experienced by participants, 
N = 29
Condition n (%)
Arthritis 10 (34.5)
High cholesterol 5 (17.2)
Hypertension 6 (20.7)
Depression 4 (13.8)
Circulatory problems 4 (13.8)
Diabetes 3 (10.3)
Stroke 1 (3.4)
Chest problems 4 (13.8)
Heart problems 2 (6.9)
Visual impairment 1 (3.4)
Thyroid problems 2 (6.9)
Bowel problems 1 (3.4)
Swallowing problems 1 (3.4)
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she just said, “Well you have to wait,” … I 
didn’t have a very positive experience with 
the results process.’ (B1, F)
 
‘… certainly, when I was waiting for my 
results, I’d asked the consultant anyway 
and he’d give me a pretty good idea, and 
then I went to wait, and that is quite, that’s 
awful because it’s just like a letter just 
drops and they don’t even bother ringing 
up […]’ (B1, F)
It was suggested that the FDS could 
help by setting expectations and ensuring 
accountability: 
‘The good thing about that sort of 
measurement though is it is from the 
patient’s point of view, you will get your 
result within 28 days, you know, that you 
can understand that and there’s a lot of 
detailed questions about it, but it’s aimed at 
telling you what to expect.’ (G1, M)
Clarifying the role of patients in the 
referral process
Participants wanted to be offered the choice 
of where and when to attend follow-up 
appointments, to be seen as quickly as 
possible, and know where they were in 
the system. Systems enabling this kind 
of independent involvement, for example, 
‘choose and book’, were perceived as 
beneficial to re-establish a sense of agency, 
based on direct experience: 
‘The thing that swung it for me is that I 
deliberately chose to go to the one that was 
further away so it was longer to drive to, but 
I would be seen quicker and immediately 
without waiting in the waiting room area, 
and it was, it was instant, I was just straight 
in, straight out, and a free car park! ’ (G1, F) 
‘I know I’m not lost in the system because I 
am making the appointment and I’m going 
to get an answer today and I’m going to get 
something in my diary today because I’m 
the one doing it and I haven’t got to wait at 
home for the referral.’ (G2, F)
However, participants did not always 
consider their involvement legitimate, 
perceiving common strategies such 
as taking cancellations to get an earlier 
appointment as manipulating the system: 
‘I just rang direct, and said, “Look, have 
you got any cancellations?” and I got one 
the next day … there’s a lot of people that 
cancel, and don’t turn up, and they have 
spaces and they know if they can fit you in 
for that amount of time because they know 
what you’re going for, it’s easy done. I know 
the system.’ (B2, F)
GPs were considered facilitators in 
this process because they had access 
to information that patients might not, 
and could also legitimise these ways of 
navigating the referral process: 
‘I think a discussion with GP would be an 
important thing here, because GPs are 
in, they have the authority to direct you to 
the certain location for which consultant, 
which hospital you should go for this test, 
that hospital, the GPs would know all this, 
that hospital takes longer and getting the 
results back, so it would be up to the GP to 
sort of see what the patient wants …’ (B1, M)
When people considered their role in 
meeting standards such as the FDS, it was 
felt that patients should not need to be 
involved as the responsibility lay with health 
professionals:
‘The point of having performance standards 
such as this is to drive up standards generally 
on the performance of the cancer team or 
whatever, you know, and to minimise the 
requirement for us the users to be being 
involved in that process, the responsibility 
for performance lies with the leadership 
team, or within the NHS, or wherever it 
is, and therefore in my view, you know, 
there shouldn’t be a need for the users 
to have to get involved in this because the 
whole point of having those performance 
standards is to make sure that the service 
that’s being delivered is efficient and people 
know generally within 28 days.’ (B2, M)
Patients were considered to be passive 
players in a complex system, as described 
previously. However, some recognised that 
the public could play a role in the process 
and meeting the 28-day standard:
‘If everybody has a role then the system 
should become more seamless anyway, 
if everybody takes ownership for their 
own condition or responsibility of the 
appointments and things, like turning up 
and not cancelling it at the last minute and 
having that role, then surely that would 
make it easier for them to stick to the 
28 days.’ (G1, F)
FDS considered complex to measure or 
deliver
Cynicism was widespread regarding 
achievement of FDS targets in primary and 
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secondary care, within the constraints of a 
compartmentalised system:
‘It doesn’t rely on one person, or one 
department, there’s so many variables, if 
you went into a department and they said, 
“We will do this and get you in the following 
day,” you would say, “Oh OK,” you know, we 
would get on board with that, but going from 
the GP to the consultant to the radiologist to 
somebody else, to somebody else, there’s 
so many variables in the process I don’t 
think it can be achieved.’ (B1, M)
An even more extreme view was that 
it represented a mere ‘tick box’ exercise, 
lacking meaningful change for patients:
‘You can tell that amongst the group we 
look at that and we’re immediately thinking, 
how are they going to wriggle and fiddle to 
meet that in a way that we will then think, 
well you met the target, but it’s still rubbish, 
you know, that there’s too much missing, 
there’s too much ambiguity in that and you 
don’t measure one thing, you know.’ (G1, M)
Focus group conversations arose from 
a general understanding that the standard 
was designed to expedite cancer diagnosis. 
However, when the ‘ruling-out’ angle 
was considered, some were doubtful that 
this would provide answers, or a relevant 
diagnosis within the specified timeframe:
‘You go for a test and it’s usually to rule out 
something, that’s what you get told isn’t it, 
“We want to just rule a few things out,” so 
you have whatever the test is, and it does 
rule it out, but then that’s the end of the 
line, it stops, and that’s what I find really 
annoying, I’ve still got the symptoms, I’ve 
still got the pain, I’ve still got what was the 
reason I came to see you in the first place.’ 
(G1, F)
‘It says certain clinical tests, so who decides 
what tests are going to be done, because 
I mean are we saying that some tests will 
discover all cancers, or we think you might 
have this cancer therefore we’re going to 
give you this test, if it comes back clear you 
don’t have any cancer, it’s a bit ambiguous.’ 
(G2, M) 
DISCUSSION 
Summary
The researchers in the present study 
explored public attitudes towards being 
referred by a GP for clinical tests and, for 
the first time, used this backdrop to explore 
attitudes towards the new Faster Diagnosis 
Standard, which will be introduced 
in England in 2020. Males and females 
referred by their GP for diagnostic testing 
in the past 6 months discussed their views 
and experiences in four focus groups. Most 
had experienced fast referral, and found it 
difficult to understand how the new standard 
could decrease time spent progressing 
through the system. Speed was just one 
factor that was considered important when 
being referred for clinical tests: reassurance, 
feeling listened to, and transparency within 
the process were also highly valued. Where 
responsibility lay for meeting the standard 
was considered unclear, and participants did 
not necessarily view their own behaviours to 
secure an appointment or obtain test results 
as a form of involvement in this. The GP’s 
role was conceptualised as communicating 
with them about their referral, establishing 
their information needs, and maintaining 
involvement at each stage of the referral 
process. Reflecting on their own recent 
experiences, one of the main concerns was 
the process of waiting for and obtaining test 
results: people felt strongly that they did not 
want to receive results by letter and should 
not have to chase them.
Strengths and limitations
These findings are the first to illuminate 
public attitudes towards the FDS. By 
drawing upon recent referral experiences 
of the public, this study provides insight 
into factors for consideration by doctors 
and wider stakeholder groups, ensuring 
public views are taken into account as the 
standard is rolled out. A major strength is 
the development of key recommendations 
in collaboration with patients with cancer, 
members of the public, and academic 
experts in primary care and cancer 
diagnosis. It should be recognised that 
these findings are specific to those who 
were given an all clear for cancer, but 
this comprises 90% of people referred for 
clinical tests in this context.3 However, this 
means the authors cannot draw conclusions 
about the experiences or attitudes towards 
the FDS of those with a previous or current 
cancer diagnosis.
The authors included clinical tests from 
their previous research in primary care16 
but acknowledge that the broad spectrum 
of tests meant not everyone in the present 
study would have been referred according 
to a cancer pathway and there would have 
been variation in how people received their 
test results. However, the authors felt it 
was important to keep the range broad 
because, first, their main aim was to use 
people’s referral experiences to anchor the 
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conversation about the FDS and, second, 
that people may not have known that they 
were referred on a cancer pathway and so 
may have been unnecessarily excluded. 
Future research could further delineate 
patient experiences of referral by exploring 
different ways of accessing diagnostic tests, 
for example, ‘straight to test’, referral to a 
specialist or multi-diagnostic centre and 
so on, and how these influence the patient 
pathway. 
Importantly, views of GPs and other 
healthcare professionals should be 
considered before FDS roll-out, as recent 
evidence suggests GPs in the UK were 
less likely to retain responsibility for patient 
follow-up compared with non-UK GPs.19 
Finally, purposive sampling helped promote 
diversity, with equal sex representation 
and inclusion of differing ethnic groups, 
educational backgrounds, and geography, 
though the authors acknowledge that 
another limitation is that the sample was 
still mainly white British and well educated. 
Comparison with existing literature 
A recent King’s Fund-commissioned 
inquiry paper20 highlighted the importance 
of a feeling that progress is being made 
through the system following GP referral,21 
suggesting that providing information 
regarding the referral process can increase 
patient satisfaction.22 This supports 
the need for balance between speed of 
referral or testing and care aspects such 
as information, trust, and communication.
In the present study, the GP was 
identified as having a key role in maintaining 
this balance, including signposting to 
appropriate services and determining how 
much information to provide about the 
referral, based on their knowledge of the 
patient and their support needs. Previous 
studies also identified the importance of 
patients feeling they are listened to, or 
taken seriously, by the GP,23,24 receiving 
advice from the GP regarding choice of 
hospital,25 and having their information and 
support needs understood. In addition, it 
was also considered important for GPs 
to have time to provide information and 
reassurance.26,27
Difficulties obtaining test results are a 
common experience for patients.28–30 In 
the present study, participants sometimes 
obtained results from the specialist but 
in the majority of cases obtained them 
from the GP, or had to wait for a letter. 
Letters have been identified previously as 
a slow form of communication for results 
of importance,28,31,32 and communication by 
letter held strong negative connotations for 
participants in the current study. Similar 
to findings by Litchfield et al,30 patients felt 
that while it is necessary to chase up results 
when they had not been communicated, it 
should not have to fall to them to do so. 
Participants saw the FDS as a way of 
clarifying when they could rightfully phone 
to chase test results, but the majority felt 
28 days was too long to wait for suspected 
cancer, and they would contact providers 
sooner than this. Previous qualitative 
studies have shown that patients who went 
on to have a cancer diagnosis considered 
a 2-week wait to be too long, provoking 
anxiety.23,33 Awareness of current standards 
for diagnostic referral for cancer was 
low within the group, with both over- and 
underestimates of waiting timeframes 
reported by participants within discussions. 
This finding is supported by other qualitative 
research indicating low awareness of 
current urgent referral pathways for cancer 
diagnosis.34 While participants in the 
present study did not have a diagnosis of 
cancer, many conveyed an expectation that 
their progress through the pathway would 
be speedier if cancer was highly suspected. 
Low awareness of current norms may 
therefore contribute to the perception that 
28 days is too long to wait to have cancer 
ruled in or out. 
Implications for practice
The study findings provide an evidence base 
upon which to make recommendations 
that may help GPs and other healthcare 
professionals when the FDS is introduced. 
These recommendations are summarised 
as follows: 
• Patients should be asked what they 
would like to know about the diagnostic 
testing process, encompassing referral, 
specialist input, testing, and obtaining 
results.
• Where appropriate, GPs should be more 
transparent about the referral process 
and the potential for lack of clarity around 
next steps, timescales, and outcomes.
• Patients should know that it is acceptable 
to make use of opportunities perceived as 
‘manipulating the system’, for example, 
phoning up to offer to take a cancellation 
at short notice. However, care needs to 
be taken to avoid adding to symptom 
burden by forcing responsibilities upon 
the patient. 
• Results should be communicated 
according to the patient’s preference, 
and ideally not via letter (without other 
support or follow-up).
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Among people recently referred for 
clinical tests by their GP, speed of referral 
was merely one of a number of priorities for 
improving their experience. The introduction 
of the FDS may therefore provide an 
opportunity to address these other 
priorities, not only by providing guidance 
to GPs who face dynamic and complex 
diagnostic processes, but to empower the 
public to play a more central part.
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